
Dameron Levest Jones
Examiner (ID: 18762, Phone: (571)272-0617 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1621, 1616, 3991, 1211, 1618, RD00, 1619, 1622, 1615 |
| Total Applications | 2574 |
| Issued Applications | 1523 |
| Pending Applications | 392 |
| Abandoned Applications | 685 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11756045
[patent_doc_number] => 20170202912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'OPTOGENETIC CONTROL OF INPUTS TO THE VENTRAL TEGMENTAL AREA'
[patent_app_type] => utility
[patent_app_number] => 15/471992
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 27724
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15471992
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/471992 | OPTOGENETIC CONTROL OF INPUTS TO THE VENTRAL TEGMENTAL AREA | Mar 27, 2017 | Abandoned |
Array
(
[id] => 11962131
[patent_doc_number] => 20170266285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING MODIFIED HEMOGLOBIN-BASED THERAPEUTIC AGENT FOR CANCER TARGETING TREATMENT AND DIAGNOSTIC IMAGING'
[patent_app_type] => utility
[patent_app_number] => 15/469978
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 10299
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15469978
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/469978 | Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging | Mar 26, 2017 | Issued |
Array
(
[id] => 17434830
[patent_doc_number] => 11260136
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Radio-pharmaceutical complexes
[patent_app_type] => utility
[patent_app_number] => 16/087040
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13079
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087040
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/087040 | Radio-pharmaceutical complexes | Mar 19, 2017 | Issued |
Array
(
[id] => 14043545
[patent_doc_number] => 20190077879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => CONJUGATES ENHANCING TOTAL CELLULAR ACCUMULATION
[patent_app_type] => utility
[patent_app_number] => 16/085141
[patent_app_country] => US
[patent_app_date] => 2017-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7066
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085141
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085141 | Conjugates enhancing total cellular accumulation | Mar 14, 2017 | Issued |
Array
(
[id] => 11713692
[patent_doc_number] => 20170182192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'METHOD OF DRY DYE DELIVERY FOR STAINING THE EYE'
[patent_app_type] => utility
[patent_app_number] => 15/459078
[patent_app_country] => US
[patent_app_date] => 2017-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2057
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15459078
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/459078 | METHOD OF DRY DYE DELIVERY FOR STAINING THE EYE | Mar 14, 2017 | Abandoned |
Array
(
[id] => 13955597
[patent_doc_number] => 20190054142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN CONNECTION WITH USE OF CONTRAST MEDIA
[patent_app_type] => utility
[patent_app_number] => 16/079787
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079787
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079787 | ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN CONNECTION WITH USE OF CONTRAST MEDIA | Feb 23, 2017 | Abandoned |
Array
(
[id] => 13955699
[patent_doc_number] => 20190054193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => ACTIVITY BASED PROBE AND USES THEREOF FOR IMAGING
[patent_app_type] => utility
[patent_app_number] => 16/077879
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077879
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077879 | Activity based probe and uses thereof for imaging | Feb 15, 2017 | Issued |
Array
(
[id] => 12001813
[patent_doc_number] => 20170305968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'PEPTIDES WHOSE UPTAKE IN CELLS IS CONTROLLABLE'
[patent_app_type] => utility
[patent_app_number] => 15/427427
[patent_app_country] => US
[patent_app_date] => 2017-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 43987
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15427427
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/427427 | PEPTIDES WHOSE UPTAKE IN CELLS IS CONTROLLABLE | Feb 7, 2017 | Abandoned |
Array
(
[id] => 12000316
[patent_doc_number] => 20170304471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'ANTICANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/427355
[patent_app_country] => US
[patent_app_date] => 2017-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14484
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15427355
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/427355 | Anticancer therapy | Feb 7, 2017 | Issued |
Array
(
[id] => 11742922
[patent_doc_number] => 20170196995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'OPTICAL IMAGING PROBES'
[patent_app_type] => utility
[patent_app_number] => 15/413139
[patent_app_country] => US
[patent_app_date] => 2017-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13421
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15413139
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/413139 | Optical imaging probes | Jan 22, 2017 | Issued |
Array
(
[id] => 16492371
[patent_doc_number] => 10858396
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => HER2 peptide regents and methods
[patent_app_type] => utility
[patent_app_number] => 15/780286
[patent_app_country] => US
[patent_app_date] => 2016-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 97
[patent_no_of_words] => 14060
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780286
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780286 | HER2 peptide regents and methods | Nov 30, 2016 | Issued |
Array
(
[id] => 16930953
[patent_doc_number] => 20210196842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => SITE-SPECIFIC RADIOFLUORINATION OF PEPTIDES WITH 8-[18F]-FLUOROOCTANOIC ACID CATALYZED BY LIPOIC ACID LIGASE
[patent_app_type] => utility
[patent_app_number] => 15/777558
[patent_app_country] => US
[patent_app_date] => 2016-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777558
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/777558 | SITE-SPECIFIC RADIOFLUORINATION OF PEPTIDES WITH 8-[18F]-FLUOROOCTANOIC ACID CATALYZED BY LIPOIC ACID LIGASE | Nov 28, 2016 | Abandoned |
Array
(
[id] => 18908935
[patent_doc_number] => 11871895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Raman spectroscopy reporters and methods for molecular imaging of tissue in vivo
[patent_app_type] => utility
[patent_app_number] => 15/778236
[patent_app_country] => US
[patent_app_date] => 2016-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 10
[patent_no_of_words] => 5342
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778236
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/778236 | Raman spectroscopy reporters and methods for molecular imaging of tissue in vivo | Nov 22, 2016 | Issued |
Array
(
[id] => 13567775
[patent_doc_number] => 20180335435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => USE OF RECEPTOR-BINDING DOMAIN DERIVED FROM BOVINE LEUKEMIA VIRUS FOR THE DIAGNOSIS OR TREATMENT OF CATIONIC L-AMINO ACID TRANSPORTER-RELATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/777087
[patent_app_country] => US
[patent_app_date] => 2016-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777087
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/777087 | Use of receptor-binding domain derived from bovine leukemia virus for the diagnosis or treatment of cationic l-amino acid transporter-related diseases | Nov 17, 2016 | Issued |
Array
(
[id] => 13604159
[patent_doc_number] => 20180353628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => Labeled Probe and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 15/775450
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11561
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775450
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/775450 | Labeled probe and methods of use | Nov 10, 2016 | Issued |
Array
(
[id] => 13604157
[patent_doc_number] => 20180353627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => RADIOLABELED DISINTEGRINS AS BRACHYTHERAPY AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/775743
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10695
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775743
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/775743 | RADIOLABELED DISINTEGRINS AS BRACHYTHERAPY AGENTS | Nov 10, 2016 | Abandoned |
Array
(
[id] => 11689666
[patent_doc_number] => 20170165382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'NANOCARRIERS FOR CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/349946
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20241
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349946
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/349946 | NANOCARRIERS FOR CANCER TREATMENT | Nov 10, 2016 | Abandoned |
Array
(
[id] => 11671567
[patent_doc_number] => 20170160287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'USE OF 7-CHLORO-N,N,5-TRIMETHYL-4-OXO-3-PHENYL-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-B] INDOLE-1-ACETAMIDE AS A BIOMARKER OF PERIPHERAL BENZODIAZEPINE RECEPTOR LEVELS'
[patent_app_type] => utility
[patent_app_number] => 15/347965
[patent_app_country] => US
[patent_app_date] => 2016-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10993
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15347965
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/347965 | USE OF 7-CHLORO-N,N,5-TRIMETHYL-4-OXO-3-PHENYL-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-B] INDOLE-1-ACETAMIDE AS A BIOMARKER OF PERIPHERAL BENZODIAZEPINE RECEPTOR LEVELS | Nov 9, 2016 | Abandoned |
Array
(
[id] => 11443059
[patent_doc_number] => 20170044080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'RADIOCONJUGATION METHOD'
[patent_app_type] => utility
[patent_app_number] => 15/340743
[patent_app_country] => US
[patent_app_date] => 2016-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9068
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15340743
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/340743 | RADIOCONJUGATION METHOD | Oct 31, 2016 | Abandoned |
Array
(
[id] => 11647950
[patent_doc_number] => 20170143851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'IMAGING AGENTS FOR IMAGING PROTEASE ACTIVITY AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/337461
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 13002
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15337461
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/337461 | Imaging agents for imaging protease activity and uses thereof | Oct 27, 2016 | Issued |